Cambridge Investment Research Advisors’s DermTech, Inc. Common Stock DMTK Stock Holding History

Cambridge Investment Research Advisors’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,241	Closed	-$15K	–	3321
2023 Q3	$15K	Buy	+10,241	New	+$25.6K	﹤0.01%	3098
2023 Q2	–	Sell	-11,649	Closed	-$43K	–	3318
2023 Q1	$43K	Buy	11,649 +1,391	+14%	+$5.86K	﹤0.01%	3052
2022 Q4	$18K	Sell	10,258 -3,102	-23%	-$8.25K	﹤0.01%	3052
2022 Q3	$53K	Buy	13,360 +801	+6%	+$4.93K	﹤0.01%	2932
2022 Q2	$70K	Buy	+12,559	New	+$103K	﹤0.01%	2907
2021 Q4	–	Sell	-7,892	Closed	-$253K	–	3294
2021 Q3	$253K	Buy	7,892 +1,981	+34%	+$69.6K	﹤0.01%	2615
2021 Q2	$246K	Sell	5,911 -15,825	-73%	-$650K	﹤0.01%	2636
2021 Q1	$1.1M	Buy	+21,736	New	+$1.14M	0.01%	1372

Other funds holding DMTK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCBWMS

Texas Capital Bank Wealth Management Services Dallas, Texas $1.87B AUM 24.49% 1-Year Est. Return

Cambridge Investment Research Advisors's DMTK Position: Q4 2023 in Review

Cambridge Investment Research Advisors sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2023, closing a stake of 10,241 shares — an estimated $15K sold.

Cambridge Investment Research Advisors first reported a position in DMTK in Q1 2021 and held it in 8 quarters. The position peaked at $1.1M in Q1 2021. 77 funds tracked by Wall St. Rank hold DMTK as of Q4 2023.

Cambridge Investment Research Advisors reported no remaining DermTech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Cambridge Investment Research Advisors sold 10,241 DermTech, Inc. Common Stock shares in Q4 2023, an estimated $15K.
Cambridge Investment Research Advisors first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
Cambridge Investment Research Advisors's DermTech, Inc. Common Stock position peaked at $1.1M in Q1 2021.
77 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.